CT Lung Imaging Combined with Machine Learning Predicts Further COPD Care
|
By MedImaging International staff writers Posted on 24 Jun 2022 |

Healthcare utilization in chronic obstructive pulmonary disease (COPD) patients is a growing concern. Patients with COPD are more likely to utilize healthcare services, have higher rates of hospitalizations and hospital readmissions, and higher rates of mortality. Hence, predicting increased risk of future healthcare utilization in COPD patients is important for improving patient management. Now, a new study has found that healthcare utilization could potentially be predicted in mild COPD patients using computed tomography (CT) lung imaging and machine learning.
The study by researchers at the Toronto Metropolitan University (Toronto, ON, Canada) aimed to determine the importance of CT lung imaging measurements relative to other demographic and clinical measurements for predicting future health services use with machine learning in COPD. In the retrospective study, the researchers evaluated lung function measurements and chest CT images of 527 COPD participants from 2010 to 2017. Up to two follow-up visits (1.5- and 3-year follow-up) were performed and participants were asked for details related to healthcare utilization. Healthcare utilization was defined as any COPD hospitalization or emergency room visit due to respiratory problems in the 12 months prior to the follow-up visits.
The researchers found that out of the 527 COPD participants evaluated, 179 (35%) used healthcare services at follow-up. There were no significant differences between the participants with or without healthcare utilization at follow-up for age, sex, BMI or pack-years. The accuracy for predicting subsequent healthcare utilization was 80% when all measurements were considered, 76% for CT measurements alone and 65% for demographic and lung function measurements alone. Based on these findings, the researchers concluded that a combination of CT lung imaging and conventional measurements leads to greater prediction accuracy of subsequent health services use than conventional measurements alone, and may provide needed prognostic information for patients suffering from COPD.
Related Links:
Toronto Metropolitan University
Latest General/Advanced Imaging News
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
- Hybrid AI System Improves Early Lung Cancer Detection on CT
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
Channels
Radiography
view channel
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read more
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







